HALIX is a fast growing, biopharmaceutical contract development and manufacturing organization (CDMO) focused on viral vector and recombinant protein products.
As much as we'd like to discuss in person your #GMP manufacturing needs, the current situation doesn't allow us. Don’t let the distance prevent the #success of your #biotech manufacturing! Meet our business development team at this year's digital #BIOEurope partnering! @EBDgroup
New cGMP facility starting operational production in Q4-2019.
HALIX has met their major milestone with the interim delivery of their new 6,700 m2 cGMP facility for the development and production of biopharmaceutical drug substances.
https://t.co/yO8zv0n9US
#HALIX#CDMO
Everything is prepared and we are ready for the #BIO2019 in Philadelphia, USA! Our #biotech experts Roland Hecht, Nigel Stapleton and Jos Vergeest look forward to meeting you.
@BIOConvention, 03-06 June, Philadelphia, USA, Booth 2432
Only two weeks to go until the @BIOConvention in Philadelphia starts.
We already started our partnering activities. Looking forward to meeting with #biotech and #pharma companies and discuss the possibilities of #GMPmanufacturing with HALIX! #HALIX#BIO2019
With an official ground-breaking ceremony, @HALIX_CMO has kicked off the construction activities for a 6.700 m² brand-new GMP facility at the @Leidenbsp. This new facility will enable HALIX to further expand its business.
HALIX Bioscience as a service!
Mooi zeg! @UniLeiden en @HALIX_CMO (onderdeel van Hal Allergy #Leiden) ondertekenen leveringsakte voor grond. HALIX bouwt op @Leidenbsp een mooi nieuw pand dat in 2019 klaar is. Verder versterking van het cluster #lifesciences & #health@PROVADAre
https://t.co/Np0R0ZSbvM
Bestuursleden Harry Flore en Thijs de Kleer van OV BSP ontvouwen de plannen voor het park voor de komende jaren in samenwerking met haar partners @Leidenbsp tijdens Connecting the #dots